These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 5136739)

  • 1. [Active complement, its damaging effect on tissues and its possible significance for the initial arteriosclerotic process. Outline to a hypothesis].
    Geertinger P; Sorensen H
    Ugeskr Laeger; 1971 Nov; 133(47):2319-21. PubMed ID: 5136739
    [No Abstract]   [Full Text] [Related]  

  • 2. An attempt to identify the components of complement in rat serum immunoelectrophoretically.
    Slopek S; Ladosz J; Grzybek-Hryncewicz K
    Arch Immunol Ther Exp (Warsz); 1965; 13(3):324-30. PubMed ID: 5837182
    [No Abstract]   [Full Text] [Related]  

  • 3. [Experimental immune arteriosclerosis of rabbits. Immunoenzymatic study].
    Scebat L; Groult N; Renais J
    Pathol Biol (Paris); 1984 Dec; 32(10):1004-10. PubMed ID: 6393007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible contribution of the complement system to the inflammatory state.
    Hadding U
    Agents Actions Suppl; 1980; 7():24-32. PubMed ID: 7018199
    [No Abstract]   [Full Text] [Related]  

  • 5. [Complement determination and paper electrophoretic studies of the rat serum in Masugi nephritis].
    Protsch G
    Acta Biol Med Ger; 1967; 18(2):251-7. PubMed ID: 5586806
    [No Abstract]   [Full Text] [Related]  

  • 6. [Autoimmune aspects of the humoral picture in arteriosclerotic disease].
    Fiorentini P; Evangelisti GB; Marabini GF
    G Clin Med; 1971 Sep; 52(9):666-80. PubMed ID: 5149802
    [No Abstract]   [Full Text] [Related]  

  • 7. The preparation and properties of alexinated intermediates that react with conglutinin. II. Equine, rabbit and human complement.
    Lachmann PJ; Liske R
    Immunology; 1966 Sep; 11(3):255-62. PubMed ID: 5922093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Spontaneous aortic lesions in the rabbit. Possible role of immune mechanisms].
    Scebat L; Renais J; Groult N
    Paroi Arterielle; 1980; 6(1):37-45. PubMed ID: 6999426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on immune adherence (C3b) receptor activity of human erythrocytes: relationship between receptor activity and presence of immune complexes in serum.
    Inada Y; Kamiyama M; Kanemitsu T; Hyman CL; Clark WS
    Clin Exp Immunol; 1982 Oct; 50(1):189-97. PubMed ID: 6216998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Significance of the mesenchymal metabolism for the development of heart muscle necroses and arteriosclerosis].
    Hauss WH; Schmitt G
    Z Gesamte Inn Med; 1968 Feb; 23(4):58-9. PubMed ID: 5686878
    [No Abstract]   [Full Text] [Related]  

  • 11. Cytotoxins - cause of serum activity as complement in the lymphocytotoxic test.
    Májský A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(6):745-51. PubMed ID: 6176497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Complement as a factor in arteriosclerosis].
    Geertinger P; Sorensen H
    Nord Med; 1970 May; 83(19):588-90. PubMed ID: 5426426
    [No Abstract]   [Full Text] [Related]  

  • 13. [Early phases of the arteriosclerotic process].
    Weber G
    Minerva Med; 1973 Apr; 64(24):1218-20. PubMed ID: 4707405
    [No Abstract]   [Full Text] [Related]  

  • 14. [On the use of flourescein isothiocyanate labelled anticomplement serum for the Goldwasser-Shepard test].
    Kishko IaG
    Mikrobiol Zh; 1965; 27(5):67-70. PubMed ID: 5330200
    [No Abstract]   [Full Text] [Related]  

  • 15. Serum bactericidal activity and phagocytosis in host defence against Haemophilus ducreyi.
    Lagergård T; Frisk A; Purvèn M; Nilsson LA
    Microb Pathog; 1995 Jan; 18(1):37-51. PubMed ID: 7783597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Observations on the mechanism of immune hemolysis: importance of immunoglobulin class and source of complement on the extent of damage.
    Frank MM; Dourmashkin RR; Humphrey JH
    J Immunol; 1970 Jun; 104(6):1502-10. PubMed ID: 5452415
    [No Abstract]   [Full Text] [Related]  

  • 17. [Significance of arterial hypertension in the pathogenesis of arteriosclerotic vascular changes].
    Hecht A
    Z Gesamte Inn Med; 1980 Oct; 35(19):suppl 101-3. PubMed ID: 7210748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of immune precipitation by complement.
    Schifferli JA; Bartolotti SR; Peters DK
    Clin Exp Immunol; 1980 Nov; 42(2):387-94. PubMed ID: 6781802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement-mediated inhibition of immune precipitation. I. Role of the classical and alternative pathways.
    Schifferli JA; Woo P; Peters DK
    Clin Exp Immunol; 1982 Mar; 47(3):555-62. PubMed ID: 6979442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Behavior of serum lipids, blood coagulation factors, platelet aggregation, complement and serum immunoglobulins in a group of arteriosclerotic, hyperlipemic subjects treated with 3GS].
    D'Eredità F; Avellone G; Novo S; Davì G; Abruzzese G; Di Liberti M; Pinto A; Riolo F
    Clin Ter; 1981 Feb; 96(3):303-24. PubMed ID: 7307448
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.